ASL reveals regional brain perfusion impairment in neonates with mild hypoxic ischemic encephalopathy

Mario Cirillo1, Simona Puzone2,3, Alessandro Pasquale De Rosa1

  • 1Department of Advanced Medical and Surgical Sciences, Advanced MRI Research Center, University of Campania "Luigi Vanvitelli", Naples, Italy.

Scientific Reports
|August 27, 2025
PubMed

Insights

Cerebral blood flow in the basal ganglia is a key biomarker for neurodevelopmental outcomes in infants with mild hypoxic-ischaemic encephalopathy (HIE), even without visible deep brain injury on MRI scans.

Area of Science:

  • Neonatal Neurology
  • Neuroimaging
  • Biomarker Discovery

Background:

  • Mild hypoxic-ischaemic encephalopathy (HIE) lacks established neuroimaging biomarkers.
  • Cerebral reperfusion injury is a potential outcome marker in moderate/severe HIE.
  • Arterial spin labelling (ASL) can assess cerebral blood flow (CBF).

Purpose of the Study:

  • To investigate ASL-derived CBF in infants with mild HIE.
  • To associate CBF with neurodevelopmental outcomes.
  • To explore regional sensitivity of CBF to HIE severity.

Main Methods:

  • Prospective cohort study of term/near-term neonates with HIE (n=94).
  • MRI-ASL performed 4-10 days post-birth.
  • Neurodevelopmental outcome assessed at 24-28 months using Bayley scales.

Main Results:

  • Basal ganglia CBF significantly correlated with cognitive, motor, and language scores (FDR < 0.05).
  • HIE severity showed regional effects on CBF (Heschl, Rolandic operculum, limbic lobe, subcortical gray nuclei, frontal lobes).
  • Mild HIE with normal deep nuclei MRI still showed basal ganglia CBF association with adverse outcomes.

Conclusions:

  • Basal ganglia CBF is a potential biomarker for neurodevelopmental outcomes in mild HIE.
  • ASL can detect subtle perfusion changes indicative of risk.
  • Regional CBF analysis provides insights into HIE's impact on brain development.